Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz
NCT05041010
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
496
Enrollment
INDUSTRY
Sponsor class
Conditions
Ischemic Stroke
Interventions
DRUG:
Neu2000KWL group
DRUG:
Placebo group
Sponsor
GNT Pharma